Click to View Image
C28H35FO7 502.57

Pregna-1,4-diene-3,20-dione, 21-(acetyloxy)-16,17-[cyclopentylidenebis(oxy)]-9-fluoro-11-hydroxy-, (11,16)-.
9-Fluoro-11,16,17,21-tetrahydroxypregna-1,4-diene-3,20-dione cyclic 16,17-acetal with cyclopentanone, 21-acetate [51022-69-6].
» Amcinonide contains not less than 97.0 percent and not more than 102.0 percent of C28H35FO7, calculated on the dried basis.
Packaging and storage— Preserve in well-closed containers.
B: Ultraviolet Absorption 197U
Solution: 40 µg per mL.
Medium: methanol.
Absorptivities at 238 nm, calculated on the dried basis, do not differ by more than 3.0%.
Specific rotation 781S: between +89.4 and +94.0.
Test solution: 10 mg per mL, in chloroform.
Loss on drying 731 Dry it at 105 for 4 hours: it loses not more than 1.0% of its weight.
Solution A— Prepare a filtered and degassed mixture of water and acetonitrile (13:7).
Solution B— Prepare a filtered and degassed mixture of acetonitrile and water (7:3).
Mobile phase— Use variable mixtures of Solution A and Solution B as directed for Chromatographic system. Make adjustments to either Solution as necessary (see System Suitability under Chromatography 621).
System suitability solution— Dissolve suitable quantities of butylparaben and USP Amcinonide RS in Solution B to obtain separate solutions containing 12.5 µg per mL and 20 µg per mL, respectively.
Standard preparation— Dissolve an accurately weighed quantity of USP Amcinonide RS in Solution B, and dilute quantitatively, and stepwise if necessary, with Solution B to obtain a solution having a known concentration of about 0.02 mg per mL.
Assay preparation— Transfer about 20 mg of Amcinonide, accurately weighed, to a 100-mL volumetric flask, dissolve in and dilute with Solution B to volume, sonicate for 5 minutes, and mix. Transfer 5 mL of this solution to a 50-mL volumetric flask, dilute with Solution B to volume, and mix.
Chromatographic system (see Chromatography 621)—The liquid chromatograph is equipped with a 254-nm detector and a 4.6-mm × 25-cm column that contains packing L1, and is programmed to provide variable mixtures of Solution A and Solution B. The flow rate is about 2 mL per minute. Equilibrate the system with Solution A. From 2.5 minutes to 10 minutes after injection, linearly increase the amount of Solution B to 100%. Chromatograph the System suitability solution, and record the peak responses as directed under Procedure: the relative retention times are about 0.78 for butylparaben and 1.0 for amcinonide, and the resolution, R, between butylparaben and amcinonide is not less than 8.0. Chromatograph the Standard preparation, and record the peak responses as directed for Procedure: the tailing factor is not more than 1.5, and the relative standard deviation for replicate injections is not more than 2.0%.
Procedure— Separately inject equal volumes (about 10 µL) of the Standard preparation and the Assay preparation. Record the chromatograms, and measure the responses for the major peaks. Calculate the quantity, in mg, of C28H35FO7 in the portion of Amcinonide taken by the formula:
1000C(rU / rS)
in which C is the concentration, in mg per mL, of USP Amcinonide RS in the Standard preparation; and rU and rS are the peak responses obtained from the Assay preparation and the Standard preparation, respectively.
Auxiliary Information— Please check for your question in the FAQs before contacting USP.
Topic/Question Contact Expert Committee
Monograph Daniel K. Bempong, Ph.D.
Senior Scientist
(MDPS05) Monograph Development-Pulmonary and Steroids
Reference Standards Lili Wang, Technical Services Scientist
USP32–NF27 Page 1505
Chromatographic Column—
Chromatographic columns text is not derived from, and not part of, USP 32 or NF 27.